Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Cefapirin is a first generation cephalosporin indicated in the treatment of susceptible bacterial infections. Cefapirin (INN, also spelled cephapirin), commonly marketed under the trade name Cefadyl, is a first-generation cephalosporin antibiotic that is available in injectable formulations.
- Mechanism
- Curator reviewed
The bactericidal activity of cephapirin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
- Primary indication
- For treatment of infections caused by susceptible bacteria.Curator reviewed · 7 structured indications
- Formula / weight
- C17H17N3O6S2 · 423.463 g/mol (avg)
- Also known as
- Cefaprin · Cephapirin · Cephapirine
Resolves to
UQLLWWBDSUHNEB-CZUORRHYSA-NSMILES[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)CSC1=CC=NC=C1)C(O)=OWhat you can answer from here — as of September 13, 2026
Which drugs share a target with Cefapirin, and which of those have an active Phase 3 trial?